A detailed history of Ewa, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ewa, LLC holds 1,057 shares of LLY stock, worth $927,517. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,057
Previous 942 12.21%
Holding current value
$927,517
Previous $716 Million 29.6%
% of portfolio
0.38%
Previous 0.32%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $83,360 - $104,539
115 Added 12.21%
1,057 $928 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $79,947 - $106,957
135 Added 16.73%
942 $716 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $525 - $619
1 Added 0.12%
807 $539 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $29,124 - $40,153
67 Added 9.07%
806 $494 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $13,328 - $17,821
38 Added 5.42%
739 $347 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $217,751 - $255,738
701 New
701 $305 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ewa, LLC Portfolio

Follow Ewa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.